TCRX · TScan Therapeutics, Inc. · Held by Funds
Substantial doubt about the company's ability to continue as a going concern.
“However, substantial doubt about the Company's ability to continue as a going concern exists. ... These conditions raise substantial doubt about the Company's ability to continue as a going concern. ... Therefore, substantial doubt about the Company's ability to continue as a going concern has not been alleviated.”View the 10-Q filed Aug 12, 2026
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Fund Ownership of TCRX by Fund Type
Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026Index funds and index ETFs hold 4.10% of shares outstanding.
| Fund type | Of shares outstanding | Shares |
|---|---|---|
| Index funds | 0.79% | 532,795 |
| Index ETFs | 3.31% | 2,243,440 |
| Active ETFs | 0.00% | 0 |
| Active funds | 1.01% | 681,718 |
| Unclassified | 0.10% | 69,487 |
| All registered funds | 5.20% | 3,527,440 |
How fund types are measured
Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.
Funds holding TCRX
22 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 1,500,337 | $1,470,480 | 0.00% | Long | 2026-06-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 575,570 | $564,116 | 0.00% | Long | 2026-06-30 | |
| BlackRock Health Sciences Term Trust | BMEZ | 405,905 | $397,827 | 0.04% | Long | 2026-06-30 | |
| Fidelity Extended Market Index Fund | FSMAX | 293,642 | $317,133 | 0.00% | Long | 2026-05-31 | |
| iShares Micro-Cap ETF | IWC | 167,533 | $164,199 | 0.01% | Long | 2026-06-30 | |
| Fidelity Total Market Index Fund | FSKAX | 87,566 | $94,571 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | FCFMX | 72,914 | $78,747 | 0.00% | Long | 2026-05-31 | |
| Multi-Manager Small Cap Equity Strategies Fund | CZMSX | 69,487 | $75,046 | 0.01% | Long | 2026-05-31 | |
| Ultra-Small Company Market Fund | BRSIX | 70,400 | $68,999 | 0.05% | Long | 2026-06-30 | |
| SMALL CAP EQUITY FUND | — | 65,813 | $64,503 | 0.01% | Long | 2026-06-30 | |
| NVIT Multi-Manager Small Company Fund | — | 44,500 | $43,614 | 0.01% | Long | 2026-06-30 | |
| NVIT Small Cap Value Fund | — | 39,000 | $38,224 | 0.02% | Long | 2026-06-30 | |
| Strategic Advisers U.S. Total Stock Fund | FSAKX | 29,612 | $31,981 | 0.00% | Long | 2026-05-31 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 28,767 | $31,068 | 0.00% | Long | 2026-05-31 | |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | — | 29,605 | $29,016 | 0.00% | Long | 2026-06-30 | |
| VANGUARD BALANCED INDEX FUND | — | 19,320 | $18,936 | 0.00% | Long | 2026-06-30 | |
| Blackstone Alternative Multi-Strategy Fund | — | 12,000 | $11,761 | 0.00% | Long | 2026-06-30 | |
| 1290 VT Micro Cap Portfolio | — | 11,250 | $11,026 | 0.01% | Long | 2026-06-30 | |
| Small-Mid Cap Equity Fund | TSGUX | 1,462 | $6,974 | 0.00% | Long | 2024-11-30 | |
| JNL/DFA U.S. Small Cap Fund | — | 3,238 | $3,174 | 0.00% | Long | 2026-06-30 | |
| State Street Balanced Index Fund | SSBIX | 713 | $699 | 0.00% | Long | 2026-06-30 | |
| Knights of Columbus U.S. ALL CAP INDEX FUND | — | 303 | $225 | 0.00% | Long | 2026-07-31 |